Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease

被引:28
作者
Di Renzo, M
Rubegni, P
Pasqui, AL
Pompella, G
de Aloe, G
Sbano, P
Cuccia, A
Castagnini, C
Auteri, A
Pasini, FL
Fimiani, M
机构
[1] Univ Siena, Dept Internal Med, I-53100 Siena, Italy
[2] Univ Siena, Dept Immunol, I-53100 Siena, Italy
[3] Univ Siena, Dept Dermatol, I-53100 Siena, Italy
关键词
chronic graft-versus-host disease; cytokine; extracorporeal photopheresis; monocyte;
D O I
10.1111/j.1365-2133.2005.06482.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Chronic graft-versus-host disease (cGVHD) is a major complication of allogeneic bone marrow transplantation. Extracorporeal photopheresis (ECP) has recently been introduced as an alternative treatment for cases of cGVHD refractory to conventional immunosuppressive treatment, but its mechanism of action is not yet clear. Objectives To investigate in seven patients with cGVHD the effects of ECP on resistance of monocytes to apoptosis and on monocyte cytokine production. Methods We designed an in vitro model that could mimic the potential in vivo effect of reinfusion of peripheral blood mononuclear cells treated by ECP. The model was based on coculture of ECP-treated lymphocytes with untreated monocytes from the same patient. Results ECP did not accelerate spontaneous apoptosis of monocytes. However, ECP-treated monocytes produced increased amounts of interleukin (IL)-12. In contrast, IL-12 production by monocytes did not increase in cocultures, but IL-10 production was upregulated. Conclusions These results suggest that reinfusion of large numbers of autologous apoptotic lymphocytes is significant for the therapeutic outcome of ECP through upregulation of IL-10, which is an immunosuppressive cytokine.
引用
收藏
页码:59 / 65
页数:7
相关论文
共 30 条
  • [21] Cytokine therapy of cutaneous T-cell lymphoma: interferons, interleukin-12, and interleukin-2
    Rook, AH
    Kuzel, TM
    Olsen, EA
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2003, 17 (06) : 1435 - +
  • [22] Extracorporeal photophoresis in chronic cutaneous graft-versus-host disease
    Russell-Jones, R
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 (07) : 621 - 623
  • [23] Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response
    Seaton, ED
    Szydlo, RM
    Kanfer, E
    Apperley, JF
    Russell-Jones, R
    [J]. BLOOD, 2003, 102 (04) : 1217 - 1223
  • [24] Apoptosis: the quiet death silences the immune system
    Sun, EW
    Shi, YF
    [J]. PHARMACOLOGY & THERAPEUTICS, 2001, 92 (2-3) : 135 - 145
  • [25] Extracorporeal photopheresis induces lymphocyte but not monocyte apoptosis
    Tambur, AR
    Ortegel, JW
    Morales, A
    Klingemann, H
    Gebel, HM
    Tharp, MD
    [J]. TRANSPLANTATION PROCEEDINGS, 2000, 32 (04) : 747 - 748
  • [26] The important balance between cytokines derived from type 1 and type 2 helper T cells in the control of graft-versus-host disease
    Tanaka, J
    Imamura, M
    Kasai, M
    Hashino, S
    Kobayashi, S
    Noto, S
    Higa, T
    Sakurada, K
    Asaka, M
    [J]. BONE MARROW TRANSPLANTATION, 1997, 19 (06) : 571 - 576
  • [27] Augmentation of monocyte interleukin-8 production by psoralen/UVA-treated CD4+ T cells
    Tokura, Y
    Seo, N
    Tomida, M
    Sarukawa, M
    Hashizume, H
    Takigawa, M
    Moriwaki, S
    [J]. EXPERIMENTAL DERMATOLOGY, 2002, 11 (06) : 564 - 572
  • [28] Tokura Y, 2001, ANN NY ACAD SCI, V941, P185
  • [29] Immunosuppressive effects of apoptotic cells
    Voll, RE
    Herrmann, M
    Roth, EA
    Stach, C
    Kalden, JR
    Girkontaite, I
    [J]. NATURE, 1997, 390 (6658) : 350 - 351
  • [30] EXTRACORPOREAL PHOTOCHEMOTHERAPY INDUCES THE PRODUCTION OF TUMOR-NECROSIS-FACTOR-ALPHA BY MONOCYTES - IMPLICATIONS FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA AND SYSTEMIC-SCLEROSIS
    VOWELS, BR
    CASSIN, M
    BOUFAL, MH
    WALSH, LJ
    ROOK, AH
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (05) : 686 - 692